Product Information
SUMATRIPTAN SUCC 50 MG TABLET is a generic product labeled by Bionpharma Inc., priced at $0.3319 per EA under NDC 69452034572. Its NADAC has been published 195 times since Oct 5, 2022.
The Low Outlier badge above means this manufacturer's average price in the Sumatriptan market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Bionpharma Inc.NDC
69452034572
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA078284On Market Since
2/18/2022
Pharmacological Classes
Price Statistics
The NADAC for SUMATRIPTAN SUCC 50 MG TABLET has been published 195 times since Oct 5, 2022, and over the history we have for it it has declined 38.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3319 per EA |
|---|---|
| All-time high | $0.5357 (Oct 12, 2022) |
| All-time low | $0.3029 (Nov 20, 2024) |
| 52-week high | $0.3579 |
| 52-week low | $0.3231 |
| Median price | $0.3746 |
| Average price | $0.3854 |
| Largest weekly change | +31.3% (Aug 21, 2024) |
| Weeks tracked | 195 |
| Tracking since | Oct 5, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SUMATRIPTAN SUCC 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN SUCC 50 MG TABLET, manufactured by Bionpharma Inc., is $0.3319 per EA (NDC 69452034572), effective Jun 24, 2026.
How has the price of SUMATRIPTAN SUCC 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for SUMATRIPTAN SUCC 50 MG TABLET has declined 38.0%. It has been tracked across 195 weekly CMS publications since Oct 5, 2022.
What are the highest and lowest recorded NADAC prices for SUMATRIPTAN SUCC 50 MG TABLET?
Since Oct 5, 2022, the NADAC for SUMATRIPTAN SUCC 50 MG TABLET has ranged from a low of $0.3029 (Nov 20, 2024) to a high of $0.5357 (Oct 12, 2022), with a median of $0.3746 per EA.
Are there cheaper alternatives to SUMATRIPTAN SUCC 50 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, SUMATRIPTAN SUCC 50 MG TABLET, is $0.3104 per EA — about 6% below SUMATRIPTAN SUCC 50 MG TABLET.
Who manufactures SUMATRIPTAN SUCC 50 MG TABLET?
SUMATRIPTAN SUCC 50 MG TABLET (NDC 69452034572) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification